By Professor Bruce Neal

Journal articles

Finfer SR; Bellomo R; Myburgh J; Norton RS, 2003, 'Efficacy of albumin in critically ill patients', British Medical Journal: International, 326, pp. 559 - 560

, 2003, 'International Society of Hypertension (ISH)', Journal of Hypertension, 21, pp. 665 - 672, http://dx.doi.org/10.1097/00004872-200304000-00003

Neal B; Gray H; MacMahon S; Dunn L, 2002, 'Incidence of heterotopic bone formation after major hip surgery', ANZ Journal of Surgery, 72, pp. 808 - 821, http://dx.doi.org/10.1046/j.1445-2197.2002.02549.x

Dudman N; Hunt D; MacMahon S; Neal B; Richards M; Simes J; Tonkin A; Wilcken D; Murphy J; Cleverly Y; Keech A; Ohkubo T; Brnabic A, 2002, 'Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease', JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, 3, pp. 270 - 276, http://dx.doi.org/10.3317/jraas.2002.049

Gu DF; Reynolds K; Wu XG; Chen J; Duan XF; Muntner P; Huang GY; Reynolds RF; Su SY; Whelton PK; He J, 2002, 'Prevalence, awareness, treatment, and control of hypertension in China', HYPERTENSION, 40, pp. 920 - 927, http://dx.doi.org/10.1161/01.HYP.0000040263.94619.D5

Dudman N; Hunt D; MacMahon S; Neal B; Richards M; Simes J; Tonkin A; Wilcken D; Murphy J; Cleverly Y; Keech A; Ohkubo T; Bos K; Bartram H; Bennett D; Broad J; Douglas D; Fisher S; Gray B; Milne A; McCulloch A; Ng C; Pledger M; Pryor A; Santos A; Slater A; Yiu K; Brnabic A; Woodward M; Burrell L; Brown L; Hamer A; Roberts L; Jeffery I; Taverner P; Kam A; Aylward P; Wollaston F; Whitehead A; Lane G; Tulloch G; Forrest N; Garrett J; Aroney G; Hicks P; Silberberg J; Gordon A; Holliday J; Hicks L; Singh B; Singh C; Wilken J; Jackson B; Rudge G; West M; Carle A; Marwick T; Hall C; Cross D; Craw D; Hunt D; Sallaberger M; Horowitz J; Worthley M; Owen L; Owensby D; McKenzie B; Kesby-Smith J; MacKinley S; Sharpe N; Doughty R; Pomfret J; Richards M; Buttimore R; Skelton L; Williams M; Stewart R; McLelland M; Luke R; Kenyon J; Mann S; Cuthbert A; Reubin S; Yorke P; Scott D; Williams M; Coxon R; Fry D; Clark M; Barclay P; Hart H; O'Toole C; Wright P; Nairn L; Bruning J, 2002, 'Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease', European Heart Journal, 23, pp. 1509 - 1515, http://dx.doi.org/10.1053/euhj.2002.3161

Watanabe M; Barzi F; Neal B; Ueshima H; Miyoshi Y; Okayama A; Reza Choudhury S, 2002, 'Alcohol consumption and the risk of diabetes by body mass index levels in a cohort of 5,636 Japanese', Diabetes Research and Clinical Practice, 57, pp. 191 - 197, http://dx.doi.org/10.1016/S0168-8227(02)00083-9

Neal B, 2001, 'Review: ACE inhibitors, calcium antagonists, and more intensive blood pressure lowering strategies reduce cardiovascular events', Evidence-Based Medicine, 6, pp. 111, http://dx.doi.org/10.1136/ebm.6.4.111

Cruickshank J, 2001, 'The lowering of blood pressure after stroke', LANCET, 358, pp. 1994 - 1994, http://dx.doi.org/10.1016/S0140-6736(01)06981-1

MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J, 2001, 'The lowering of blood pressure after stroke - Reply', LANCET, 358, pp. 1994 - 1995, http://dx.doi.org/10.1016/S0140-6736(01)06982-3

Cates C; Upton MN; D'Ambrosio M; Cruickshank J; MacMahon S; Rodgers A; Neal B; Woodward M; Chalmers J; Fournier A; Mazouz H; Choukroun G; Andrejak M; Godefroy O; Staessen JA; Wang JG; Thijs L, 2001, 'The lowering of blood pressure after stroke [1] (multiple letters)', Lancet, 358, pp. 1993 - 1996, http://dx.doi.org/10.1016/S0140-6736(01)06978-1

, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)', LANCET, 358, pp. 1556 - 1556, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000172055800065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Macmahon S; Tonkin A; Neal B; Hunt D; Richards M; Simes J; Wilcken D; Murphy J, 2001, 'Effects of omapatrilat on blood pressure and neurohormone levels among 723 individuals with coronary heart disease - The PACIFIC study', CIRCULATION, 104, pp. 601 - 601, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000171895002822&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

MacMahon S; Neal B; Tzourio C; Rodgers A; Woodward M; Cutler J; Anderson C; Chalmers J; Ohkubo T; Bouser MG; Davis S; Donnan G; Hansson L; Harrap S; Lees KR; Liu L; Mancia G; Omae T; Reid J; Sega R; Terent A; Warlow C; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Collins R; Sandercock P; Simes J; Sleight P; Brnabic A; Colman S; Francis L; Lee A; Gong L; Bousser MG; Yamaguchi T; William F; Deng Q; Hu DX; Wang W; Wu AL; Ma LY; Tao ZY; Biousse V; Berthet K; Ben Slamia L; Le Denmat C; Crespi S; Foglia G; Fujimoto C; Matsumura S; Marttala K; Pettersson M; Safwenberg M; Fenton J; McIlvenna Y; Currie R; Bartram H; Briad J; Clague A; Cleverly Y; Cosson M; Culpan A; Douglas D; Flett S; Gray B; Holloway T; Milne A; Prasad R; Ratnasabapathy Y; Santos A; Wills M; Agnew T; Chapman N; Lewis N; Mullane B, 2001, 'Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack', Lancet, 358, pp. 1033 - 1041, http://dx.doi.org/10.1016/S0140-6736(01)06178-5

Chalmers J; Cooper M; Ferrannini E; Glasziou P; Grobbee D; Hamet P; Harrap S; Liu L; MacMahon S; Mancia G; Marre M; Matthews D; Mogensen C; Neal B; Yu Pan C; Poulter N; Rodgers A; Williams B; Woodward M; Collins R; Sandercock P; Sleight P; Holman R; Fulcher G; Pollock C; Celermajer D; Watson J; Harrisberg B; Currie R; Girgis S; Jayne K; Monaghan H; Patel A; Richens A; Gray B; Milne A; Adderkin A; Bak A; Flett S; De Guise D; Jetses E; Reid J; Stolk R; Wang W; Williams F; Zou X, 2001, 'Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation', Diabetologia, 44, pp. 1118 - 1120, http://dx.doi.org/10.1007/s001250100612

Neal B, 2001, 'Commentary: Changing population blood pressure levels', British Medical Journal, 322, pp. 888 - 889

Neal B; MacMahon S; Tonkin A; Dudman N; Hunt D; Richards M; Simes J; Wilcken D; Brnabic A; Murphy J; Cleverley Y, 2001, 'Dose-dependent effects of folic acid on plasma homocysteine levels among 723 individuals with coronary heart disease: the PACIFIC study', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 37, pp. 280A - 280A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000166914401286&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chapman N; Neal B, 2001, 'Prospectively designed overviews of recent trials comparing antihypertensive regimens based on different drug classes', Current Hypertension Reports, 3, pp. 340 - 349, http://dx.doi.org/10.1007/s11906-001-0097-4

Chalmers J, 2001, 'Rationale and design of the advance study: A randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus', Journal of Hypertension, Supplement, 19

Neal B; MacMahon S; Chapman N; Cutler J; Fagard R; Whelton P; Yusuf S; Agodoa L; Baigent C; Black H; Boissel JP; Brenner B; Brown M; Bulpitt C; Byington R; Chalmers J; Collins R; Dahlof B; Davis B; Estacio R; Fox K; Hansson L; Holman R; Hunsicker L; Kostis J; Kuramoto K; Kusek J; Lees R; Lewis E; Lindholm LH; Liu L; Lubsen J; Malacco E; Mancia G; Martin I; Pepine C; Pfeffer M; Pitt B; Poole-Wilson P; Remuzzi G; Rodgers A; Ruggenenti P; Schrier R; Sever P; Sleight P; Staessen J; Teo K; Turner R; Wing L; Zanchetti A; Algert C; Woodward M, 2000, 'Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials', Lancet, 356, pp. 1955 - 1964, http://dx.doi.org/10.1016/S0140-6736(00)03307-9

Chalmers J; Neal B; MacMahon S, 2000, 'PROGRESS (Perindopril Protection Against Recurrent Stroke Study): Regional characteristics of the study population at baseline', Journal of Hypertension, Supplement, 18

MacMahon S; Neal B, 2000, 'Differences between blood-pressure-lowering drugs', Lancet, 356, pp. 352 - 353, http://dx.doi.org/10.1016/S0140-6736(00)02521-6

O Brien J; Duncan H; Kirsh G; Allen V; King P; Hargraves R; Mendes L; Perera T; Catto P; Schofield S; Ploschke H; Hefner T; Churchland M; Woolnough S; Wuttke R; Manning M; Jeffries T; Hensley L; Bath P; Bainbridge D; Guinane F; McMahon L; Zavattaro D; Wilson D; Blake K; Morton J; Sharman D; Locke R; Ghabrial J; McNeil S; Rehfisch P; Van Der Merwe S; Einoder B; Douglas D; Ashwell J; Morrissey A; Brown A; Simm R; Fisch C; Crawford W; Everding T; Tanham D; Hooper J; Aldana C; Goldwasser M; Mibus M; Rowden N; Mills J; Johnson P; Stilwell J; Williams R; Stevenson T; Zwar J; Bauze R; Nyunt B; Russell R; Day G; Cameron M; Clements P; Beck T; Ellis A; Phipps S; Quaill W; Skirving A; McGuiness M; Gray P; Rankin J; Wood D; Senior J; Courtenay B; Green M; Harris I; Rush J; Kilgour M; Davies J; Newcombe J; Lewis C; Leitl S; Chilcott R; Pianta R; Aguila A; Hawe C; Nade S; Smith M; Robertson P; Rothwell A; May S; Williams S; Rothwell A; Shamy S; Martin G; Steele V; Jeffery K; Kelman I; McKillan J; Dayaram P; Culling J; Lawson D; Winfield P; Kuzel R, 2000, 'Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial', Lancet, 355, pp. 1295 - 1302, http://dx.doi.org/10.1016/S0140-6736(00)02110-3

Neal BC; Rodgers A; Clark T; Gray H; Reid IR; Dunn L; MacMahon SW, 2000, 'A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery', Acta Orthopaedica Scandinavica, 71, pp. 122 - 128, http://dx.doi.org/10.1080/000164700317413076

Neal BC; Rodgers A; Gray H; Clark T; Beaumont DD; House T; Douglas JE; Reid IR; MacMahon SW, 2000, 'No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: A randomized trial of 2,649 patients', Acta Orthopaedica Scandinavica, 71, pp. 129 - 134, http://dx.doi.org/10.1080/000164700317413085

Neal B; Rodgers A; Dunn L; Fransen M, 2000, 'Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.', Cochrane database of systematic reviews (Online)

Neal B, 2000, 'UNDER THE MICROSCOPE', Evidence-based Cardiovascular Medicine, 4, pp. 28 - 30, http://dx.doi.org/10.1054/ebcm.2000.0286

Zhang X; MacMahon S; Rodgers A; Neal B, 1999, 'Determinants of cardiovascular disease in the Asian Pacific Region: Protocol for a collaborative overview of cohort studies', CVD Prevention, 2, pp. 281 - 289

Rodgers A; Neal B, 1999, 'Less salt does not necessarily mean less taste', Lancet, 353, pp. 1332, http://dx.doi.org/10.1016/S0140-6736(99)01198-8

Chalmers J; MacMahon S; Mancia G; Whitworth J; Beilin L; Hansson L; Neal B; Rodgers A; Mhurchu CN; Clark T, 1999, '1999 World Health Organization International Society of Hypertension guidelines for the management of hypertension', JOURNAL OF HYPERTENSION, 17, pp. 151 - 183, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000079235700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chalmers J, 1999, '1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension', Blood Pressure, Supplement, 8, pp. 9 - 43

Chalmers J; MacMahon S; Bousser MG; Cutler J; Donnan G; Hansson L; Harrap S; Liu L; Mancia G; Omae T; Reid J; Rodgers A; Warlow C, 1999, 'PROGRESS - Perindopril Protection Against Recurrent Stroke Study: Characteristics of the study population at baseline', Journal of Hypertension, 17, pp. 1647 - 1655

Neal B; MacMahon S, 1999, 'The world health organization- international society of hypertension blood pressure lowering treatment trialists' collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments', Current Hypertension Reports, 1, pp. 346 - 356, http://dx.doi.org/10.1007/s11906-999-0045-2

Neal B, 1999, 'Captopril and conventional treatment had similar effects on cardiovascular morbidity and mortality in patients with primary hypertension', Evidence-based Cardiovascular Medicine, 3, pp. 74 - 74, http://dx.doi.org/10.1054/ebcm.1999.0232

Black H; Boissel JP; Brenner B; Brown M; Bulpitt C; Chalmers J; Collins R; Cutler J; Dahlof B; Davis B; Fagard R; Fletcher A; Furberg C; Hansson L; Kuramoto K; Lewis E; MacMahon S; Mancia G; Pitt B; Poulter N; Remuzzi G; Sleight P; Turner R; Sever P; Whelton P; Wing L; Yusuf S; Zanchetti A; Martin I; Cohn J; Alderman M; Hansson L; Neal B; Rodgers A; Baigent C; Collins R, 1998, 'Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments', Journal of Hypertension, 16, pp. 127 - 137

NEAL B, 1998, 'Blood pressure and the risk of recurrent vascular disease', American Journal of Hypertension, 11, pp. 25A - 25A, http://dx.doi.org/10.1016/s0895-7061(97)90792-5

Alderman M; Arakawa K; Beilin L; Chalmers J; Cohn J; Collins R; Fenichel RR; Frohlich ED; Hamet P; Hansson L; Hennekens C; Kuschnir E; Lisheng L; MacMahon S; Mancia G; Martin I; Menard J; Sleight P; Whitworth J; Yusuf S; Zanchetti A; Neal B, 1997, 'Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding', Hypertension Research - Clinical and Experimental, 20, pp. 61 - 72

MacMahon S; Rodgers A; Neal B; Chalmers J, 1997, 'Blood pressure lowering for the secondary prevention of myocardial infarction and stroke', Hypertension, 29, pp. 537 - 538, http://dx.doi.org/10.1161/01.HYP.29.2.537

Chalmers J, 1997, 'Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding', Journal of Human Hypertension, 11, pp. 331 - 342, http://dx.doi.org/10.1038/sj.jhh.1000467

Neal B; Rodgers A; Mackie MJ; MacMahon S, 1996, 'Forty years of randomised trials in the New Zealand Medical Journal', New Zealand Medical Journal, 109, pp. 372 - 373

Neal B; Anderson C; Chalmers J; MacMahon S; Rodgers A, 1996, 'Blood pressure lowering in patients with cerebrovascular disease: Results of the progress (perindopril protection against recurrent stroke study) pilot phase', Clinical and Experimental Pharmacology and Physiology, 23, pp. 444 - 446, http://dx.doi.org/10.1111/j.1440-1681.1996.tb02758.x

Neal B; MacMahon S, 1995, 'PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee [corrected]', Journal of hypertension, 13, pp. 1869 - 1873

Neal B; MacMahon S; Bousser MG; Chalmers J; Cutler J; Donnan G; Hansson L; Harrap S; Lisheng L; Mancia G; Menard J; Omae T; Reid J; Rodgers A, 1995, 'The PROGRESS study: Rationale and design', Journal of Hypertension, 13, pp. 1869 - 1873, http://dx.doi.org/10.1097/00004872-199512010-00068

Conference Papers

Neuen BL; Oshima M; Perkovic V; Arnott C; Bakris G; Cannon CP; Charytan DM; Jardine M; Levin A; Neal B; Pollock C; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 2647 - 2647, http://dx.doi.org/10.26190/unsworks/28409

Vaduganathan M; Sattar N; Xu J; Butler J; Mahaffey KW; Neal B; Shaw W; Rosenthal N; Pfeifer M; Hansen MK; Januzzi JL; Neal B, 2021, 'Multi-marker biomarker panel, adverse cardiovascular and kidney outcomes, and response to canagliflozin in the CANVAS Program', in EUROPEAN JOURNAL OF HEART FAILURE, WILEY, Online Congress, pp. 270 - 270, presented at Heart Failure 2021 and the World Congress on Acute Heart Failure, Online Congress, 29 June 2021 - 01 July 2021, http://dx.doi.org/10.1002/ejhf.2297

Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris GL; Brenner BM; Charytan D; de Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine M; Levin A; Li J-W; Neal B; Pollock C; Wheeler D; Zhang H; Zinman B; Mahaffey KW, 2019, 'Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c < 7%: Results From the CREDENCE Trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, PA, Philadelphia, presented at Scientific Sessions of the American-Heart-Association, PA, Philadelphia, 16 November 2019 - 18 November 2019, http://dx.doi.org/10.26190/unsworks/27739

Huang L; Trieu K; Yoshimura S; Woodward M; Campbell N; Lackland D; Leung A; Anderson CAM; MacGregor G; Neal B; He F, 2019, 'Impact of dose and duration of dietary salt reduction on blood pressure levels: systematic review and meta-analysis of randomised trials', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, FRANCE, Paris, pp. 989 - 989, presented at Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology, FRANCE, Paris, 31 August 2019 - 04 September 2019, http://dx.doi.org/10.26190/unsworks/28689

Perkovic V; Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine M; Bakris G, 2018, 'Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease', in DIABETOLOGIA, SPRINGER, GERMANY, Berlin, pp. S39 - S39, presented at 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), GERMANY, Berlin, 01 October 2018 - 05 October 2018, http://dx.doi.org/10.26190/unsworks/28688

Huang L; Tian M; Li N; Elliot P; Yan L; Labarthe D; Yin X; Wu Y; Hao Z; Liu Y; Shi J; Feng X; Zhang J; Zhang Y; Zhang R; Neal B, 2018, 'A13076 Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS)', in Journal of Hypertension, Wolters Kluwer, PEOPLES R CHINA, Beijing, pp. e279, presented at 27th Scientific Meeting of the International-Society-of-Hypertension, PEOPLES R CHINA, Beijing, 20 September 2018 - 23 September 2018, http://dx.doi.org/10.1097/01.hjh.0000549138.27560.0d

Mahaffey KW; Neal B; Perkovic V; de Zeeuw D; Fulcher G; Erondu N; Shaw W; Sun T; Desai M; Matthews DR, 2017, 'Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, CA, Anaheim, pp. E454 - E455, presented at Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, CA, Anaheim, 11 November 2017 - 15 November 2017, http://dx.doi.org/10.26190/unsworks/28470

Back to profile page